HEALTH

Calif. to debate classification of pseudoephedrine products

BY Michael Johnsen

SACRAMENTO, Calif. The California Senate Appropriations Committee was slated to debate Tuesday Senate Bill 484, which would reclassify pseudoephedrine products as a schedule-V drug, making them only available by prescription in that state.

While California is not alone in considering pushing PSE products from their behind-the-counter status to actual prescription-only status, PSE legislation in this state has gained momentum. Prescription-only legislation also has gained traction in Missouri, according to published reports. PSE currently is prescription-only in Oregon.

“In our ongoing effort to preserve the $750 million market for OTC PSE products, [the Consumer Healthcare Products Association] and its member companies are fighting prescription bills in a number of states this year,” stated GMDC in a message to its constituents on Friday. “CHPA is working with a strong coalition, including NACDS and the California retailers and grocers associations to oppose the bill, but it is backed by the state attorney general, the state board of pharmacy and numerous law enforcement groups.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Study finds link between vitamin D deficiency, bacterial vaginosis

BY Michael Johnsen

BETHESDA, Md. There may be a link between vitamin D deficiency and bacterial vaginosis, a vaginal infection that is common among pregnant women and can lead to complications.

According to data to be published in the June 2009 issue of the Journal of Nutrition, researchers tracking 469 pregnant women found that 41% of those women had BV, and that the prevalence of BV decreased as vitamin D concentration increased.

Researchers concluded that vitamin D insufficiency is associated with BV in the first four months of pregnancy. Further, poor vitamin D status may contribute to the strong racial disparity in the prevalence of BV in U.S. women. Controlled intervention trials will be needed to confirm this hypothesis, the researchers suggested.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

IRI study: Consumers not worried about catching H1N1 virus

BY Michael Johnsen

CHICAGO Almost half of Americans (45%) are not concerned about getting a contagious disease like the novel influenza A (H1N1) virus, according to a new consumer survey conducted by Information Resources Inc.

However, that doesn’t mean Americans aren’t looking to actively protect themselves from catching the flu — 54% reported that they would wash their hands more frequently, 24% suggested they would venture out into the public less often and 20% said they would buy more alcohol-based or antibacterial hand cleaners in an effort to prevent infection.

“This epidemic announcement has caught the shoppers’ attention,” Thomas Blischok, president of consulting and innovation, IRI, told Drug Store News. “And their immediate [reaction] was to buy more hand sanitizers [and] any sort of ‘safety’-related products.”

Sales in those hand sanitizers and related products — like N95 masks, for example — spiked in the immediate aftermath of the H1N1 announcement but have dropped since. That could change this fall if the story of an H1N1 return to the U.S. dominates news broadcasts, as is likely, Blischok suggested, and retailers need to be prepared. For the retailer developing a strategy around this now, Blischok said, “it might be good to begin analyzing their data and understand exactly about people who were concerned about [H1N1] changed their purchase behaviors.”

Many of those products — hand sanitizers, facemasks, thermometers, even prescription antiviral medications — were reported out-of-stock when news of H1N1 first broke, Blischok noted. Now, retailers have a few months to prepare for an expected resurgence in demand around those products.

“I can even see the development of a ‘flu avoidance’ endcap,” Blischok said. “Information [and communication] will be key; understanding what people will buy will be key; [and] being very clear that you have the right assortment to support flu prevention will be key.”

Another important issue, especially for pharmacy operators, is the dissemination of information, Blischok said. Once alerted to the potential of a pandemic, Blischok said, consumers turned to their healthcare resources, such as the pharmacist, for more information.

“The clinics inside the drug stores have a great opportunity to really over-communicate things you can do to prevent flu, to avoid flu,” Blischok added. “The stores that have clinics can really win here, because they can do some diagnostics, etc., and really help people understand exactly the kinds of behaviors they should be undertaking to give themselves the greatest chance of not getting the flu.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?